[HTML] thelancet.com

[HTML][HTML] Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in …

P Basu, SG Malvi, S Joshi, N Bhatla… - The Lancet …, 2021 - thelancet.com
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …
被引用次数：151 相关文章

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in …

P Basu, SG Malvi, S Joshi, N Bhatla… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …
[HTML] sciencedirect.com

[HTML][HTML] Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in …

P Basu, SG Malvi, S Joshi, N Bhatla, R Muwonge… - The Lancet …, 2021 - Elsevier
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …
[HTML] nih.gov

[HTML][HTML] Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in …

P Basu, SG Malvi, S Joshi, N Bhatla… - The Lancet …, 2021 - ncbi.nlm.nih.gov
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in …

P Basu, SG Malvi, S Joshi, N Bhatla… - The Lancet …, 2021 - europepmc.org
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in …

P Basu, SG Malvi, S Joshi, N Bhatla… - The lancet …, 2021 - mdanderson.elsevierpure.com
Background: A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …

Vaccine efficacy against persistent human Papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in …

P Basu, SG Malvi, S Joshi, N Bhatla, R Muwonge… - 2021 - cabidigitallibrary.org
Background: A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …
[PDF] researchgate.net

[PDF][PDF] Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls …

P Basu, SG Malvi, S Joshi, N Bhatla, R Muwonge… - Lancet …, 2021 - researchgate.net
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …
[PDF] academia.edu

[PDF][PDF] Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls …

P Basu, SG Malvi, S Joshi, N Bhatla, R Muwonge… - Lancet Oncol, 2021 - academia.edu
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in …

P Basu, SG Malvi, S Joshi, N Bhatla… - The Lancet …, 2021 - europepmc.org
Background A randomised trial designed to compare three and two doses of quadrivalent
human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort …